Artificial Intelligence in Cancer Diagnostics Market to Witness Robust Expansion by 2029

Artificial intelligence in cancer diagnostics market is anticipated to grow at a CAGR of 32.5% during the forecast period (2023-2030). Artificial Intelligence (AI) in cancer diagnostics is an automated software used for early cancer diagnostics with the help of cancer detection at early stages, proper treatment can be provided to the patients, resulting in low death rates. Several governments have increased their healthcare Information Technology (IT) expenditure, which in turn to improve healthcare infrastructure around the globe. For instance, the healthcare IT spending of the US federal government increased from $119.5 billion in 2020 to $176.5 billion in 2021. Increasing initiatives undertaken by the government to increase the adoption of AI-assisted technologies for cancer diagnosis is expected to boost the market growth.

To Request a Sample of our Report on Artificial Intelligence in Cancer Diagnostics Market:  https://www.omrglobal.com/request-sample/artificial-intelligence-in-cancer-diagnostics-market

Artificial Intelligence in Cancer Diagnostic Market Segmentation

By Application

  • Screening & Diagnosis
  • Tumor Identification
  • Surveillance

 By Type

  • Breast Cancer
  • Prostate Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Others (Cervical Cancer, Blood Cancer, Bone Cancer, and Other)
  • Artificial Intelligence in Cancer Diagnostics Market by End User
  • Hospitals
  • Diagnostic Centers
  • Research Organization
  • Medical Institute and Academics

A full Report of Artificial Intelligence in Cancer Diagnostics Market is Available @  https://www.omrglobal.com/industry-reports/artificial-intelligence-in-cancer-diagnostics-market

Regional Analysis                                                                                                                                                                            

North America                                                                                                           

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe

Asia-Pacific

  • India
  • China
  • Japan
  • South Korea
  • Rest of APAC

Rest of the World

  • Latin America
  • Middle East and Africa

Company Profiles

  • Therapixel
  • Sophia Genetics SA
  • Freenome Holdings, Inc.
  • Tempus Labs, Inc.
  • Janssen Pharmaceuticals
  • Path AI Inc.
  • DeepMind Technologies Ltd.
  • Cerner Corp.
  • RaySearch Laboratories
  • Flatiron health
  • ai
  • Oncology Analytics Inc.
  • Oncora Medical
  • Ibex Medical Analytics Ltd.
  • 4basecare Onco Solutions Pvt. Ltd .

Reasons to buy from us –

  1. We cover more than 15 major industries, further segmented into more than 90 sectors.
  2. More than 120 countries are for analysis.
  3. Over 100+ paid data sources mined for investigation.
  4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/artificial-intelligence-in-cancer-diagnostics-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404